Akanda (AKAN) Interest & Investment Income (2022)
Akanda's (AKAN) quarterly Interest & Investment Income came in at $747.0 in Q2 2022.
Akanda (AKAN) Interest & Investment Income (2022) Analysis & Trends
Akanda's Interest & Investment Income history runs 1 years deep, the most recent figure standing at $747.0 for Q2 2022.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $747.0 in Q2 2022; TTM through Jun 2022 was $747.0, a N/A change from a year earlier, with the FY2025 full-year figure at $92457.0, up 3030.95% from the prior year.
- Interest & Investment Income was $747.0 for Q2 2022 at Akanda.
- Over the last five years, Interest & Investment Income for AKAN reached as high as $747.0 in Q2 2022 and fell as low as $747.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Akanda | 996.67 Mn | 996.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 747.00 |